115 related articles for article (PubMed ID: 30829395)
1. Cerebral adrenoleukodystrophy is associated with loss of tolerance to profilin.
Orchard PJ; Nascene DR; Gupta A; Taisto ME; Higgins L; Markowski TW; Lund TC
Eur J Immunol; 2019 Jun; 49(6):947-953. PubMed ID: 30829395
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.
Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A
JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.
Weinhofer I; Rommer P; Gleiss A; Ponleitner M; Zierfuss B; Waidhofer-Söllner P; Fourcade S; Grabmeier-Pfistershammer K; Reinert MC; Göpfert J; Heine A; Yska HAF; Casasnovas C; Cantarín V; Bergner CG; Mallack E; Forss-Petter S; Aubourg P; Bley A; Engelen M; Eichler F; Lund TC; Pujol A; Köhler W; Kühl JS; Berger J
EBioMedicine; 2023 Oct; 96():104781. PubMed ID: 37683329
[TBL] [Abstract][Full Text] [Related]
5. Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.
Lund TC; Stadem PS; Panoskaltsis-Mortari A; Raymond G; Miller WP; Tolar J; Orchard PJ
PLoS One; 2012; 7(2):e32218. PubMed ID: 22359672
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy.
Taghizadeh LA; King CJ; Nascene DR; Gupta AO; Orchard PJ; Higgins L; Markowski TW; Nolan EE; Furcich JW; Lund TC
Sci Rep; 2022 May; 12(1):7985. PubMed ID: 35568699
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy.
Wang H; Davison MD; Kramer ML; Qiu W; Gladysheva T; Chiang RMS; Kayatekin C; Nascene DR; Taghizadeh LA; King CJ; Nolan EE; Gupta AO; Orchard PJ; Lund TC
Cells; 2022 Mar; 11(5):. PubMed ID: 35269535
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
9. A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis.
Hashemi E; Narain Srivastava I; Aguirre A; Tilahan Yoseph E; Kaushal E; Awani A; Kyu Ryu J; Akassoglou K; Talebian S; Chu P; Pisani L; Musolino P; Steinman L; Doyle K; Robinson WH; Sharpe O; Cayrol R; Orchard P; Lund T; Vogel H; Lenail M; Han MH; Bonkowsky JL; Van Haren KP
bioRxiv; 2023 Nov; ():. PubMed ID: 37986739
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
Shah N; Singh I
Mol Neurobiol; 2017 Mar; 54(2):1392-1403. PubMed ID: 26843114
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy.
Richmond PA; van der Kloet F; Vaz FM; Lin D; Uzozie A; Graham E; Kobor M; Mostafavi S; Moerland PD; Lange PF; van Kampen AHC; Wasserman WW; Engelen M; Kemp S; van Karnebeek CDM
Front Cell Dev Biol; 2020; 8():520. PubMed ID: 32671069
[TBL] [Abstract][Full Text] [Related]
12. Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy.
Laureti S; Falorni A; Volpato M; Casucci G; Picchio ML; Angeletti G; Luthman H; Brunetti P; Betterle C; Santeusanio F
Horm Metab Res; 1996 Jul; 28(7):319-22. PubMed ID: 8858375
[TBL] [Abstract][Full Text] [Related]
13. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy.
Baarine M; Khan M; Singh A; Singh I
PLoS One; 2015; 10(11):e0143238. PubMed ID: 26581106
[TBL] [Abstract][Full Text] [Related]
14. Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy.
Gupta A; Orchard PJ; Miller WP; Nascene DR; Raymond GV; Loes DJ; McKenna DH; Lund TC
Stem Cells Transl Med; 2020 May; 9(5):554-558. PubMed ID: 32020747
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy.
Kakumoto T; Matsukawa T; Ishiura H; Mori H; Tsuji S; Toda T
Ann Clin Transl Neurol; 2023 Jul; 10(7):1230-1238. PubMed ID: 37259474
[TBL] [Abstract][Full Text] [Related]
16. Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy.
Lund TC; Ng M; Orchard PJ; Loes DJ; Raymond GV; Gupta A; Kenny-Jung D; Nascene DR
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1894-1899. PubMed ID: 32599216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
18. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy.
Orchard PJ; Markowski TW; Higgins L; Raymond GV; Nascene DR; Miller WP; Pierpont EI; Lund TC
Sci Rep; 2019 May; 9(1):7858. PubMed ID: 31133696
[TBL] [Abstract][Full Text] [Related]
19. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation.
Schlüter A; Sandoval J; Fourcade S; Díaz-Lagares A; Ruiz M; Casaccia P; Esteller M; Pujol A
Brain Pathol; 2018 Nov; 28(6):902-919. PubMed ID: 29476661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
